Skip to main content

Share story

Infrastructure Products

Meta plans 1-petabit transatlantic cable using dual-core fiber

Meta plans 1-petabit transatlantic cable using dual-core fiber Image: Primary
Meta announced Petal, a planned 7,000-kilometer subsea cable between France and the United States that it expects to enter service in 2029 with 1 petabit-per-second capacity. NEC will manufacture and install the system, Sumitomo Electric Industries will supply its dual-core fiber, and Orange is supporting the French landing. Petal will place two optical cores inside each fiber in a 24-pair system, providing the equivalent of 48 conventional fiber pairs. Meta says this will double the capacity of its Anjana cable without a proportional increase in power and remain within existing 18-kilovolt power-equipment limits. The system is announced but not yet operating.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Engineering at Meta and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...